Motherrisk Update: Taking ACE inhibitors during pregnancy. Is it safe?

Canadian Family Physician

Volumn 48, Issue JUN., 2002, Pages 1047-1049

  Ratnapalan, Savithiri ^a   Koren, Gideon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENAZEPRIL; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; ENALAPRILAT; FOSINOPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; VASOTEC IV;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; DRUG UTILIZATION; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; ANIMAL; CONGENITAL MALFORMATION; FEMALE; NEWBORN; PREGNANCY COMPLICATION; REVIEW;

ABNORMALITIES, DRUG-INDUCED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTERS;

EID: 0036312904     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. High-risk pregnancy management options
2. Angiotensin-converting enzyme inhibitors in pregnancy
3. Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: A prospective, placebo-controlled study in baboons (Papio hamadryas)
4. Placental passage of angiotensin-converting enzyme inhibitors
5. Enalapril for pregnancy-induced hypertension: Acute renal failure in a neonate
6. Angiotensin-converting enzyme inhibitor fetopathy
7. Post marketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995
8. Drugs in pregnancy and lactation
9. Angiotensin-converting enzyme inhibitors in pregnancy: A survey of 22 patients given captopril and nine given enalapril
10. Teratogen update: Angiotensin-converting enzyme inhibitors
11. ACE inhibitors in pregnancy
12. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use
13. Neonatal anuria with maternal angiotensin-converting enzyme inhibition
14. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy
15. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy
16. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy
17. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy
18. Angiotensin-II-receptor inhibitors in pregnancy